There are so many possible news items right now it's impossible to say which one is first, but I think Kevetrin has good odds.

But then, we could get news on Prurisol. Or Brilacidin-OM. Or maybe they'll start the Brilacidin-ABSSSI trial. or..... well you get the picture.